Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial

Sophy Shih; Nathalie Davis-Lameloise; Edward Janus; Carol Wildey; Vincent Versace; Virginia Hagger; Dino Asproloupos; Sharleen O'Reilly; Paddy Phillips; Michael Ackland; Timothy Skinner; Jeremy Oats; Rob Carter; James Best; James Dunbar

doi:10.1186/1745-6215-15-259

Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial

Sophy Shih, Nathalie Davis-Lameloise, Edward Janus, Carol Wildey, Vincent Versace, Virginia Hagger, Dino Asproloupos, Sharleen O'Reilly, Paddy Phillips, Michael Ackland, Timothy Skinner, Jeremy Oats, Rob Carter, James Best, James Dunbar

Research output: Contribution to journal › Article › peer-review

9 Downloads (Pure)

Abstract

Background: The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial (RCT) that aims to assess the effectiveness of a structured diabetes prevention intervention for women who had gestational diabetes.

Methods/Design: The original protocol was published in Trials (http://www.trialsjournal.com/content/14/1/339 webcite). This update reports on an additional exclusion criterion and change in first eligibility screening to provide greater clarity. The new exclusion criterion “surgical or medical intervention to treat obesity has been added to the original protocol. The risks of developing diabetes will be affected by any medical or surgical intervention as its impact on obesity will alter the outcomes being assessed by MAGDA-DPP. The screening procedures have also been updated to reflect the current recruitment operation. The first eligibility screening is now taking place either during or after pregnancy, depending on recruitment strategy.

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Trials
Volume	15
DOIs	https://doi.org/10.1186/1745-6215-15-259
Publication status	Published - 30 Jun 2014

Access to Document

10.1186/1745-6215-15-259Licence: Other

5237832-oaFinal published version, 147 KBLicence: Other

Cite this

Shih, S., Davis-Lameloise, N., Janus, E., Wildey, C., Versace, V., Hagger, V., Asproloupos, D., O'Reilly, S., Phillips, P., Ackland, M., Skinner, T., Oats, J., Carter, R., Best, J., & Dunbar, J. (2014). Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial. Trials, 15, 1-2. https://doi.org/10.1186/1745-6215-15-259

@article{f6a222d5f36246029408b6d61fe75e73,

title = "Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial",

abstract = "Background: The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial (RCT) that aims to assess the effectiveness of a structured diabetes prevention intervention for women who had gestational diabetes. Methods/Design: The original protocol was published in Trials (http://www.trialsjournal.com/content/14/1/339 webcite). This update reports on an additional exclusion criterion and change in first eligibility screening to provide greater clarity. The new exclusion criterion “surgical or medical intervention to treat obesity has been added to the original protocol. The risks of developing diabetes will be affected by any medical or surgical intervention as its impact on obesity will alter the outcomes being assessed by MAGDA-DPP. The screening procedures have also been updated to reflect the current recruitment operation. The first eligibility screening is now taking place either during or after pregnancy, depending on recruitment strategy. ",

keywords = "article, clinical effectiveness, clinical practice, diabetes mellitus, health program, human, mother after gestational diabetes in australia diabetes prevention program, obesity, perinatal period, pregnancy, pregnancy diabetes mellitus, puerperium, risk, screening test, Australia, clinical protocol, clinical trial, controlled study, Diabetes, Gestational, female, methodology, mother, multicenter study, organization and management, patient selection, postnatal care, randomized controlled trial, recurrent disease, risk factor, risk reduction, time, treatment outcome, Clinical Protocols, Eligibility Determination, Female, Humans, Mothers, Patient Selection, Postnatal Care, Pregnancy, Recurrence, Research Design, Risk Factors, Risk Reduction Behavior, Time Factors, Treatment Outcome",

author = "Sophy Shih and Nathalie Davis-Lameloise and Edward Janus and Carol Wildey and Vincent Versace and Virginia Hagger and Dino Asproloupos and Sharleen O'Reilly and Paddy Phillips and Michael Ackland and Timothy Skinner and Jeremy Oats and Rob Carter and James Best and James Dunbar",

year = "2014",

month = jun,

day = "30",

doi = "10.1186/1745-6215-15-259",

language = "English",

volume = "15",

pages = "1--2",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

}

Shih, S, Davis-Lameloise, N, Janus, E, Wildey, C, Versace, V, Hagger, V, Asproloupos, D, O'Reilly, S, Phillips, P, Ackland, M, Skinner, T, Oats, J, Carter, R, Best, J & Dunbar, J 2014, 'Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial', Trials, vol. 15, pp. 1-2. https://doi.org/10.1186/1745-6215-15-259

TY - JOUR

T1 - Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention

T2 - An update to the study protocol for a randomized controlled trial

AU - Shih, Sophy

AU - Davis-Lameloise, Nathalie

AU - Janus, Edward

AU - Wildey, Carol

AU - Versace, Vincent

AU - Hagger, Virginia

AU - Asproloupos, Dino

AU - O'Reilly, Sharleen

AU - Phillips, Paddy

AU - Ackland, Michael

AU - Skinner, Timothy

AU - Oats, Jeremy

AU - Carter, Rob

AU - Best, James

AU - Dunbar, James

PY - 2014/6/30

Y1 - 2014/6/30

N2 - Background: The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial (RCT) that aims to assess the effectiveness of a structured diabetes prevention intervention for women who had gestational diabetes. Methods/Design: The original protocol was published in Trials (http://www.trialsjournal.com/content/14/1/339 webcite). This update reports on an additional exclusion criterion and change in first eligibility screening to provide greater clarity. The new exclusion criterion “surgical or medical intervention to treat obesity has been added to the original protocol. The risks of developing diabetes will be affected by any medical or surgical intervention as its impact on obesity will alter the outcomes being assessed by MAGDA-DPP. The screening procedures have also been updated to reflect the current recruitment operation. The first eligibility screening is now taking place either during or after pregnancy, depending on recruitment strategy.

AB - Background: The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial (RCT) that aims to assess the effectiveness of a structured diabetes prevention intervention for women who had gestational diabetes. Methods/Design: The original protocol was published in Trials (http://www.trialsjournal.com/content/14/1/339 webcite). This update reports on an additional exclusion criterion and change in first eligibility screening to provide greater clarity. The new exclusion criterion “surgical or medical intervention to treat obesity has been added to the original protocol. The risks of developing diabetes will be affected by any medical or surgical intervention as its impact on obesity will alter the outcomes being assessed by MAGDA-DPP. The screening procedures have also been updated to reflect the current recruitment operation. The first eligibility screening is now taking place either during or after pregnancy, depending on recruitment strategy.

KW - article

KW - clinical effectiveness

KW - clinical practice

KW - diabetes mellitus

KW - health program

KW - human

KW - mother after gestational diabetes in australia diabetes prevention program

KW - obesity

KW - perinatal period

KW - pregnancy

KW - pregnancy diabetes mellitus

KW - puerperium

KW - risk

KW - screening test

KW - Australia

KW - clinical protocol

KW - clinical trial

KW - controlled study

KW - Diabetes, Gestational

KW - female

KW - methodology

KW - mother

KW - multicenter study

KW - organization and management

KW - patient selection

KW - postnatal care

KW - randomized controlled trial

KW - recurrent disease

KW - risk factor

KW - risk reduction

KW - time

KW - treatment outcome

KW - Clinical Protocols

KW - Eligibility Determination

KW - Female

KW - Humans

KW - Mothers

KW - Patient Selection

KW - Postnatal Care

KW - Pregnancy

KW - Recurrence

KW - Research Design

KW - Risk Factors

KW - Risk Reduction Behavior

KW - Time Factors

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=84903330345&partnerID=8YFLogxK

U2 - 10.1186/1745-6215-15-259

DO - 10.1186/1745-6215-15-259

M3 - Article

VL - 15

SP - 1

EP - 2

JO - Trials

JF - Trials

SN - 1745-6215

ER -

Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial

Abstract

Access to Document

Other files and links

Fingerprint

Cite this